ALTERITY THERAPEUTICS LIMITED

ASX: ATH

Sector: Sector:Health Care
Industry group: Industry:Pharmaceuticals, Biotechnology & Life Sciences

Latest ATH ASX Announcements

18 Aug 2026 · 12:52 amCompany Administration
Disclosure Under Takeovers Panel GN 20
18 Aug 202612:52 amDisclosure Under Takeovers Panel GN 20Company Administration
15 Aug 2026 · 2:08 amOther
Application for quotation of securities - ATH
15 Aug 20262:08 amApplication for quotation of securities - ATHOther
12 Aug 2026 · 6:36 pmCompany Update
Granted New U.S. Composition of Matter Patent for ATH434
12 Aug 20266:36 pmGranted New U.S. Composition of Matter Patent for ATH434Company Update
11 Aug 2026 · 4:01 amOther
Application for quotation of securities - ATH
11 Aug 20264:01 amApplication for quotation of securities - ATHOther
6 Aug 2026 · 8:05 pmCompany Administration
Alterity to Present at Canaccord Genuity Growth Conference
6 Aug 20268:05 pmAlterity to Present at Canaccord Genuity Growth ConferenceCompany Administration
4 Aug 2026 · 2:22 amOther
Application for quotation of securities - ATH
4 Aug 20262:22 amApplication for quotation of securities - ATHOther
30 July 2026 · 8:00 pmQuarterly Reports
Quarterly Activities/Appendix 4C Cash Flow Report
30 July 20268:00 pmQuarterly Activities/Appendix 4C Cash Flow ReportQuarterly Reports
29 July 2026 · 7:01 pmLetters & Addresses
Upcoming Expiry of ATHO Listed Options
29 July 20267:01 pmUpcoming Expiry of ATHO Listed OptionsLetters & Addresses
28 July 2026 · 8:57 pmOther
Application for quotation of securities - ATH
28 July 20268:57 pmApplication for quotation of securities - ATHOther
22 July 2026 · 3:02 amCompany Administration
Alterity to Participate in the BTIG Biotechnology Conference
22 July 20263:02 amAlterity to Participate in the BTIG Biotechnology ConferenceCompany Administration
21 July 2026 · 11:00 pmOther
Application for quotation of securities - ATH
21 July 202611:00 pmApplication for quotation of securities - ATHOther
10 July 2026 · 1:52 amPeriodic Reports
ATH Receives A$3.98m R&D Tax Incentive
10 July 20261:52 amATH Receives A$3.98m R&D Tax IncentivePeriodic Reports
9 July 2026 · 9:40 pmOther
Application for quotation of securities - ATH
9 July 20269:40 pmApplication for quotation of securities - ATHOther
7 July 2026 · 7:44 pmCompany Update
FDA Meeting Minutes Confirm Registrational Path for ATH434
7 July 20267:44 pmFDA Meeting Minutes Confirm Registrational Path for ATH434Company Update
2 July 2026 · 2:51 amOther
Application for quotation of securities - ATH
2 July 20262:51 amApplication for quotation of securities - ATHOther

View complete ATH announcement history →